Praxis Precision Medicines (PRAX) Equity Ratio: 2022-2025
Historic Equity Ratio for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to 0.87.
- Praxis Precision Medicines' Equity Ratio fell 5.73% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 5.73%. This contributed to the annual value of 0.92 for FY2024, which is 16.40% up from last year.
- Latest data reveals that Praxis Precision Medicines reported Equity Ratio of 0.87 as of Q3 2025, which was down 2.92% from 0.89 recorded in Q2 2025.
- Praxis Precision Medicines' Equity Ratio's 5-year high stood at 0.95 during Q2 2024, with a 5-year trough of 0.66 in Q1 2023.
- Over the past 3 years, Praxis Precision Medicines' median Equity Ratio value was 0.89 (recorded in 2025), while the average stood at 0.86.
- As far as peak fluctuations go, Praxis Precision Medicines' Equity Ratio fell by 17.84% in 2023, and later spiked by 39.98% in 2024.
- Praxis Precision Medicines' Equity Ratio (Quarterly) stood at 0.66 in 2022, then climbed by 19.83% to 0.79 in 2023, then rose by 16.40% to 0.92 in 2024, then declined by 5.73% to 0.87 in 2025.
- Its Equity Ratio was 0.87 in Q3 2025, compared to 0.89 in Q2 2025 and 0.92 in Q1 2025.